Health registry for people getting a drug-coated heart stent
Part of Heart & circulation clinical trials.
This study follows people who need a coronary (heart) stent to see how they do after treatment. It does not sound like an experimental drug trial for you—it’s mainly about collecting health information after a stent procedure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be older than 19 years
- Be able to understand the study and sign consent (or your legal representative can)
- Have a narrowed heart artery (more than 50% blockage seen during the procedure)
- Have signs of reduced blood flow to the heart (like angina or a recent heart injury)—unless the blockage is very high (over 75%)
- Be able to take the needed medicines around the stent, including aspirin and a blood-thinner (clopidogrel or related drugs)
- Not be pregnant or planning pregnancy, and avoid being on certain stent-related medicines in the last 12 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people who need a heart procedure to open narrowed coronary arteries using a drug-coated stent. It aims to see how well these stents work and how people do in everyday clinical practice.
This trial tests a new type of stent (a small mesh tube) that slowly releases a medicine called sirolimus to keep your heart artery open after angioplasty. It is designed for people with narrowing in their heart arteries who need a stent.
This trial studies whether a medicine (nicorandil) given into a coronary artery during stent procedures can help keep blood flow from getting worse. It may help people having stent placement for coronary artery disease by improving how well blood moves through the treated area.
This study compares two ways of choosing blood thinners after a heart stent procedure. It aims to see if using an imaging-guided strategy leads to better outcomes than usual care.
This trial tests whether a polymer-free amphilimus-eluting stent is safe and works well for people with diabetes after a recent heart blockage procedure. It may help improve how well the artery stays open, while tracking side effects over time.
This registry enrolls adults who are about to get a heart stent and have significant blockage in their coronary arteries. It aims to collect real-world information about stenting for different types of heart conditions, which may help improve future care.
Hear when a new Coronary artery disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.